DR. BETH A BIGGEE (M.D.) – Rheumatology Physician, NPI 1750346623
Preparing for Medicare enrollment?
Use our CMS-855 prep checklist: which form applies (855I, 855O, or 855A), readiness score, NPPES field map, and Section 12 documents. Reassignment uses CMS-855I Section 4F—not the discontinued CMS-855R form.
Open Medicare 855 Prep tool →Rheumatology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
Provider Addresses for DR. BETH A BIGGEE (M.D.)
11 DURHAM DR
ANDOVER, MA 018105500
Phone: (978) 289-0163
Type: Mailing
451 ANDOVER ST STE 209
NORTH ANDOVER, MA 018455070
Phone: (978) 961-4668
Type: Location
575, Turnpike Street, North Andover Center, North Andover, Essex County, Massachusetts, 01845, United States
SUITE 11
NORTH ANDOVER, MA 018455924
Phone: (978) 794-1946
Fax: (978) 975-3925
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 4 Open Payments records for all available years, with a total value of $76.
Total Amount is formed as General ($76) + Research ($0) + Ownership ($0) = $76.
Last reported payment date: 2024-03-14 • Largest payer in this snapshot: GENZYME CORPORATION ($33).
Total Amount
$76
General + Research + Ownership
Payments
4
Total payment records
General Amount
$76
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-03-14
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| GENZYME CORPORATION | $33 |
| AstraZeneca Pharmaceuticals LP | $22 |
| PFIZER INC. | $21 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
No Medicare enrollment or revalidation data available for this provider in our database.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 13,650 | 23 | $0 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 11,200 | 17 | $0 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,000 | 11 | $0 |
| J9312 | Injection, rituximab, 10 mg | 2,450 | 11 | $0 |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | 357 | 236 | $0 |
Insurance plans in this area (ZIP 01810)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| RHEUMATOLOGY | MA | 73630 | X-ray of foot, minimum of 3 views | 22 | 22 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| - | MA | |
| - | MA | |
| - | MA |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.